Ernest Impex exports Bdparib 200 Tablet (Rucaparib 200 mg) to Washington State, USA. We offer WHO-GMP manufactured oncology medicines with bulk supply, complete export documentation, and reliable pharmaceutical distribution from India.
Product Description
Bdparib 200 Tablet is a targeted anticancer medicine formulated with Rucaparib, a PARP inhibitor that helps treat specific cancers associated with defects in DNA repair pathways.
The medicine is manufactured using advanced pharmaceutical processes under stringent quality control systems to ensure product safety, efficacy, and consistency. Every batch undergoes rigorous testing before release, making it suitable for international pharmaceutical supply.
Ernest Impex supplies Bdparib 200 Tablet to pharmaceutical importers, oncology distributors, hospitals, and healthcare organizations worldwide.
Product Overview
Product Name: Bdparib 200 Tablet
Generic Name: Rucaparib
Strength: 200 mg
Dosage Form: Film-Coated Tablet
Therapeutic Class: Anticancer Medicine (PARP Inhibitor)
Route of Administration: Oral
Bdparib 200 Tablet contains Rucaparib 200 mg, an oral anticancer medicine belonging to the class of Poly (ADP-ribose) Polymerase (PARP) inhibitors. It is prescribed for certain ovarian, fallopian tube, primary peritoneal, and prostate cancers in eligible patients as determined by an oncologist.
Key Features
- Contains Rucaparib 200 mg
- Oral targeted anticancer therapy
- WHO-GMP quality manufacturing
- High pharmaceutical purity
- Export-grade packaging
- Batch-to-batch quality consistency
- Suitable for oncology hospitals
- Reliable international supply
- Complete export documentation
- Bulk quantity available for distributors
Rucaparib-Specific Mechanism of Action
Rucaparib inhibits the activity of Poly (ADP-ribose) Polymerase (PARP-1, PARP-2, and PARP-3) enzymes, which play a critical role in repairing damaged DNA within cells.
Cancer cells with BRCA1 or BRCA2 mutations or other homologous recombination deficiencies rely heavily on PARP-mediated DNA repair for survival.
By inhibiting PARP enzymes, Rucaparib:
- Prevents repair of damaged DNA
- Causes accumulation of DNA breaks
- Promotes genomic instability in cancer cells
- Leads to selective cancer cell death while limiting effects on healthy cells
- Slows tumor progression and disease recurrence in eligible patients
This targeted mechanism makes Rucaparib an effective treatment option in selected oncology patients.
Rucaparib-Specific Recommended Dosage
Bdparib 200 Tablet should only be used under the supervision of a qualified oncologist.
The dosage depends on:
- Cancer type
- Patient's clinical condition
- Kidney and liver function
- Treatment response
- Laboratory investigations
- Occurrence of adverse reactions
Treatment modifications or dose reductions may be necessary based on individual patient tolerance.
Patients should always follow the prescribing physician's instructions and should not discontinue treatment without medical advice.
Rucaparib-Specific Side Effects
Like all anticancer medicines, Bdparib 200 Tablet may cause side effects.
Common side effects include:
- Nausea
- Vomiting
- Fatigue
- Weakness
- Anemia
- Loss of appetite
- Constipation
- Diarrhea
- Abdominal discomfort
- Altered taste sensation
Less common but serious adverse effects may include:
- Bone marrow suppression
- Elevated liver enzymes
- Increased cholesterol levels
- Photosensitivity reactions
- Myelodysplastic syndrome (MDS) or Acute Myeloid Leukemia (AML) (rare but serious)
- Severe allergic reactions
Patients should undergo regular clinical and laboratory monitoring during treatment.
Rucaparib-Specific Safety Information
- Prescription-only anticancer medicine
- Must be used under oncology specialist supervision
- Regular blood count monitoring is recommended
- Liver function tests should be monitored during therapy
- Inform your physician about all concurrent medications
- Avoid pregnancy during treatment and follow effective contraception recommendations
- Breastfeeding is generally not recommended during treatment
- Report unusual bruising, bleeding, persistent fever, or severe fatigue immediately
- Follow all prescribed monitoring schedules
Storage Information
Store Bdparib 200 Tablet:
- At controlled room temperature as indicated on the product label
- In a cool, dry place
- Away from excessive moisture
- Protect from direct sunlight
- Keep tablets in the original packaging
- Keep out of reach of children
Quality Assurance
Ernest Impex maintains stringent quality assurance systems to deliver safe and reliable oncology medicines.
Our quality standards include:
- WHO-GMP certified manufacturing
- Comprehensive raw material testing
- In-process quality monitoring
- Finished product quality analysis
- Stability studies
- Batch traceability
- Secure export packaging
- Regulatory documentation support
- International quality compliance
- Consistent manufacturing excellence
Partner with Ernest Impex
Ernest Impex is a trusted Indian pharmaceutical exporter specializing in oncology medicines for regulated and emerging international markets.
We provide:
- Bulk pharmaceutical supply
- Competitive export pricing
- Reliable international logistics
- Complete export documentation
- Dedicated customer support
- Long-term distributor partnerships
- Hospital procurement support
- Timely shipment scheduling
Our objective is to help healthcare providers worldwide access high-quality oncology medicines through dependable pharmaceutical export solutions.
FAQs
1. What is Bdparib 200 Tablet?
Bdparib 200 Tablet contains Rucaparib 200 mg, a PARP inhibitor used for treating specific types of cancer under specialist supervision.
2. What is Rucaparib used for?
Rucaparib is indicated for selected patients with ovarian, fallopian tube, primary peritoneal, and certain prostate cancers, as determined by an oncologist.
3. Is Bdparib 200 Tablet available for export to Washington State, USA?
Yes. Ernest Impex supplies Bdparib 200 Tablet for international pharmaceutical export with complete documentation.
4. Is a prescription required?
Yes. Rucaparib is a prescription-only oncology medicine.
5. Who should take Bdparib 200 Tablet?
Only patients prescribed this medicine by a qualified oncology specialist.
6. Is bulk supply available?
Yes. Ernest Impex supplies hospitals, distributors, wholesalers, and licensed pharmaceutical importers.
7. Do you provide export documentation?
Yes. Complete pharmaceutical export documentation is supplied with every shipment.
8. How should Bdparib 200 Tablet be stored?
Store according to the manufacturer's instructions in a cool, dry place away from moisture and direct sunlight.
9. Is the product manufactured under WHO-GMP standards?
Yes. The product is sourced from WHO-GMP compliant manufacturing facilities.
10. How can I request a quotation?
You can contact Ernest Impex through email or WhatsApp for pricing, product availability, and export inquiries.
Documentation
Ernest Impex provides complete export documentation, including:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- WHO-GMP Certificate
- Manufacturing License
- Product Dossier (Available on Request)
- Certificate of Pharmaceutical Product (CPP) (where applicable)
- Airway Bill (AWB) / Bill of Lading (BL)
- Shipping Documents
- Regulatory Documentation Support
Why Choose Indian Pharmaceutical Exports
India is recognized globally for producing high-quality pharmaceutical products that meet international quality standards.
Benefits of sourcing from India include:
- WHO-GMP certified manufacturing facilities
- Affordable oncology medicines without compromising quality
- Advanced pharmaceutical manufacturing technology
- Highly experienced pharmaceutical professionals
- Reliable production capacity
- Strict quality control procedures
- Complete export documentation
- Efficient international logistics support
- Competitive pricing for global buyers
- Trusted pharmaceutical export experience
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
(Group of Ernest Pharmaceutical Pvt. Ltd.)
🌐 Websites
- www.ernestimpex.com
- www.ernestvision.com
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
📧 Corporate Email
exports@ernestpharmaceuticals.com
📦 Business Type
Exporter | Bulk Supplier | Distributor
+91 93599 02383
